The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis

J Eur Acad Dermatol Venereol. 2024 Aug;38(8):e685-e688. doi: 10.1111/jdv.19845. Epub 2024 Feb 9.

Authors

C Pescia¹, G Pini¹, S Tabano^{2

3}, E Berti⁴, S Alberti Violetti^{3

4}, G A Croci^{1

3}

Affiliations

¹ Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
² Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
³ Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
⁴ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

PMID: 38334200
DOI: 10.1111/jdv.19845

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Antibodies, Monoclonal, Humanized* / therapeutic use
Female
Humans
Lymphoma, B-Cell / drug therapy
Male
Middle Aged
Pseudolymphoma* / chemically induced
Pseudolymphoma* / pathology
Psoriasis* / chemically induced
Psoriasis* / drug therapy
Skin Neoplasms / drug therapy
Skin Neoplasms / pathology

Substances

Antibodies, Monoclonal, Humanized
secukinumab